Departments
Nuclear Medicine
About
The Department of Nuclear Medicine at the German Medical Institute (GMI) offers modern and innovative diagnostic and therapeutic services that meet the highest international standards—both in terms of human expertise and technological advancement.
All diagnostic imaging procedures and treatment protocols are meticulously planned and carried out by a highly skilled, interdisciplinary team comprising Nuclear Medicine Physicians, Medical Physicists, Radiochemists, Radiology Technicians, and specially trained nursing staff.
Our team is fully committed to delivering the highest quality of care, with a strong focus on patient safety, clinical effectiveness, and dignified, compassionate service. At the heart of everything we do is our unwavering respect for the patients we serve and our dedication to their health and wellbeing.
Equipment
The PET/CT Scanner – A First in Cyprus
The PET/CT scanner, offered exclusively and for the first time in the Republic of Cyprus by the German Medical Institute (GMI), combines Positron Emission Tomography (PET) with Computed Tomography (CT) into a single, advanced diagnostic tool.
This state-of-the-art technology allows us to acquire high-resolution, highly accurate imaging, significantly enhancing our ability to detect, stage, and monitor various diseases—particularly in the fields of oncology, neurology, and cardiology.
Radiopharmaceuticals
Radiopharmaceuticals Used in PET/CT Imaging
The radiopharmaceuticals used in PET/CT imaging are considered safe, as they do not cause allergic reactions or side effects, and the administered dose is very low. The primary isotope used in all PET examinations is Fluorine-18 (^18F), which has a short half-life of 110 minutes and decays rapidly. As a result, there is no residual radioactivity in the body a few hours after the examination, and no special precautions are required following the procedure.
Depending on the clinical indication, different radiopharmaceuticals may be used to obtain the most accurate diagnostic information:
18F- FDG (radiolabelled glucose, malignancies withincreased glucose metabolism)
18F-PSMA (prostate specific membrane antigen)
18F-NaF (osseous metabolism, bone metastases)
18F-FET/18F-FLT (brain tumours)
18F-FMISO (hypoxia marker)
18F-FDOPA (presynaptic dopaminergic function)
18F-FES (estrogen receptors for breast cancer)
18F- Sifalin-TATE (somatostatin receptors in neuroendocrine tumours)
Information For Each Examination
FOR THE 18F-FDG-PET/CΤ
FOR THE18F-PSMA-PET/CT
FOR THE 18F-NaF-PET/CT
FOR THE 18F-FET/FLT-PET/CT
FOR THE 18F-FMISO-PET/CT
FOR THE 18F-FDOPA-PET/CT
FOR THE 18F-FES-PET/CT
FOR THE 18F-Sifalin-TATE-PET/CT
RESCHEDULING OR CANCELING AN EXAMINATION
Radioisotopes therapy ward
Radioisotope Therapy Ward – Department of Nuclear Medicine, GMI
The Radioisotope Therapy Ward at the German Medical Institute (GMI) comprises five spacious and fully equipped single rooms, each offering access to a radioactivity-protected private garden. This unique design allows patients to move freely, enjoy fresh air, take short walks, and interact with others—without being confined to their rooms during treatment.
In this dedicated ward, we provide advanced treatments using radioactive iodine for both benign and malignant thyroid diseases, including high-dose therapies for patients with distant metastases.
We also offer radium-223 (Xofigo®) therapy for patients with hormone-resistant prostate cancer and bone metastases, enhancing quality of life and disease control.
As pioneers in the era of theranostics, GMI was among the first centres in the region to offer targeted radioisotope therapies for:
Metastatic castration-resistant prostate cancer
Neuroendocrine tumors
These therapies use 177Lu (Lutetium-177) or 225Ac (Actinium-225) to deliver precision treatment directly to cancer cells while sparing surrounding healthy tissue.
This advanced approach reflects our commitment to personalised medicine, combining diagnostics and targeted therapy for improved outcomes and patient safety.
Department
The Department of Nuclear Medicine includes a fully integrated diagnostic unit, offering PET/CT imaging, outpatient services for thyroid patients, and a dedicated radioisotope therapy ward for the management of various malignancies, including neuroendocrine tumors and prostate cancer.
Our department is staffed by highly trained professionals who combine exceptional scientific expertise with a deep sense of professional responsibility and commitment to patient care.
We invite you to explore our department—to discover our team, our services, and the advanced medical technologies that support our work.
Should you have any questions, need clarifications, or wish to offer feedback—whether suggestions, compliments, or criticisms—we encourage you to contact us directly at:
📧 nuclear.medicine@gmi.com.cy
Our mission is to restore your health. Your feedback helps us become even better.
.webp)
Medical Staff
Contact Details
PHONE
(+357) 25 208 000
WORKING HOURS
Mon - Fri | 08:00 - 16:30
ADDRESS
1, Nikis Avenue,
4108, Agios Athanasios,
Limassol, Cyprus
